US Patent 8377446 Serum resistance factors of gram positive bacteria
Patent 8377446 was granted and assigned to Novartis on February, 2013 by the United States Patent and Trademark Office.
All edits
Edits on 4 Sep, 2024
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Patent Citations Received
Edits on 29 Nov, 2023
Golden AI
Edits made to:
Article (+136 characters)
Article
Patent abstract
A newly identified serum resistance factor of gram positive bacteria can be used to treat or prevent bacterial infection.
Edits on 20 May, 2023
Golden AI
Edits made to:
Infobox (+1/-1 properties)
US Patent 08377446 Serum resistance factors of gram positive bacteria US Patent 8377446 Serum resistance factors of gram positive bacteria
Infobox
Patent Number
0837744600
Patent Number
837744600
Edits on 24 Apr, 2023
Golden AI
Infobox
Is a
Current Assignee
Patent Jurisdiction
Patent Number
083774460
Date of Patent
February 19, 2013
0Patent Application Number
133278820
Date Filed
December 16, 2011
0Patent Primary Examiner
Edits on 27 Sep, 2022
Golden AI
Infobox
Is a
Current Assignee
Patent Jurisdiction
Patent Number
083774460
Date of Patent
February 19, 2013
0Patent Application Number
133278820
Date Filed
December 16, 2011
0Patent Primary Examiner
Edits on 15 Dec, 2021
Golden AI
Edits made to:
Infobox (+8 properties)
US Patent 08377446 Serum resistance factors of gram positive bacteria
Infobox
Is a
Current assignee
Patent jurisdiction
Patent number
08377446
Date of patent
February 19, 2013
Patent application number
13327882
Date Filed
December 16, 2011
Patent primary examiner
Find more entities like US Patent 8377446 Serum resistance factors of gram positive bacteria
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
